Scivision Biotech Inc. (1786)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
56. 00
-0.4
-0.7092%
NT$
5.91B Market Cap
15.55 P/E Ratio
- Div Yield
204,809 Volume
5.99 Eps
NT$ 56.4
Previous Close Want to track 1786 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 1.68 | - |
| | | 0.74 | 0.71 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.01 |
| | | - | - |
| | | - | 0.17 |
| | | - | 0.42 |
| | | - | 0.09 |
| | | - | 0.22 |
| | | - | - |
| | | - | - |
| | | - | 0.01 |
| | | - | 0.02 |
| | | - | 0.09 |
| | | - | 0.35 |
| | | - | 0.17 |
| | | - | 0.14 |
1786 Earnings Reports FAQ
What is the earnings per share (EPS) for 1786?
The current EPS is 5.99.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 16.16%, reflecting the 1786's performance and TWSE market conditions.
When is the next earnings release date?
Scivision Biotech Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Scivision Biotech Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1786 at this time, as Scivision Biotech Inc has no recent EPS data to calculate it.
